Arcadia Biosciences Stock Buy Hold or Sell Recommendation
| RKDA Stock | USD 2.75 0.04 1.43% |
Given the investment horizon of 90 days and your conservative risk appetite, our recommendation regarding Arcadia Biosciences is 'Strong Sell'. Macroaxis provides Arcadia Biosciences buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding RKDA positions.
Check out Arcadia Biosciences Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For information on how to trade Arcadia Stock refer to our How to Trade Arcadia Stock guide. In addition, we conduct extensive research on individual companies such as Arcadia and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Arcadia Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.
Arcadia |
Execute Arcadia Biosciences Buy or Sell Advice
The Arcadia recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Arcadia Biosciences. Macroaxis does not own or have any residual interests in Arcadia Biosciences or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Arcadia Biosciences' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Weak | Details | |
Volatility | Unstable | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Very High | Details | |
Economic Sensitivity | Hyperactively responds to market trends | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Possible Manipulator | Details |
Arcadia Biosciences Trading Alerts and Improvement Suggestions
| Arcadia Biosciences had very high historical volatility over the last 90 days | |
| Arcadia Biosciences has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 5.33 M. Net Loss for the year was (13.99 M) with loss before overhead, payroll, taxes, and interest of (2.22 M). | |
| Arcadia Biosciences currently holds about 21.23 M in cash with (15.29 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.96. | |
| Arcadia Biosciences has a frail financial position based on the latest SEC disclosures | |
| Latest headline from thelincolnianonline.com: Short Interest in Arcadia Biosciences, Inc. Declines By 21.3 |
Arcadia Biosciences Returns Distribution Density
The distribution of Arcadia Biosciences' historical returns is an attempt to chart the uncertainty of Arcadia Biosciences' future price movements. The chart of the probability distribution of Arcadia Biosciences daily returns describes the distribution of returns around its average expected value. We use Arcadia Biosciences price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Arcadia Biosciences returns is essential to provide solid investment advice for Arcadia Biosciences.
| Mean Return | 0.13 | Value At Risk | -12.63 | Potential Upside | 10.64 | Standard Deviation | 6.69 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Arcadia Biosciences historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Arcadia Stock Institutional Investors
| Shares | Royal Bank Of Canada | 2024-06-30 | 2.0 | Harbour Investments, Inc. | 2024-09-30 | 1.0 | Wells Fargo & Co | 2024-06-30 | 0.0 | Sabby Management Llc | 2024-06-30 | 0.0 | Renaissance Technologies Corp | 2024-06-30 | 0.0 | Vanguard Group Inc | 2024-09-30 | 14 K | State Street Corp | 2024-09-30 | 12.1 K | Tower Research Capital Llc | 2024-09-30 | 1.8 K | Morgan Stanley - Brokerage Accounts | 2024-09-30 | 607 | Ubs Group Ag | 2024-09-30 | 239 | Advisor Group Holdings, Inc. | 2024-06-30 | 88.0 |
Arcadia Biosciences Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change To Inventory | (1.5M) | (9.8M) | (2.4M) | 1.1M | 444K | 466.2K | |
| Change In Cash | (3.6M) | 7.6M | 12.6M | (8.0M) | (14.1M) | (13.4M) | |
| Free Cash Flow | (18.7M) | (32.6M) | (26.9M) | (14.0M) | (15.3M) | (16.1M) | |
| Depreciation | 194K | 662K | 1.0M | 479K | 984K | 506.2K | |
| Other Non Cash Items | (299K) | (15.3M) | 492K | (1M) | 499K | 524.0K | |
| Capital Expenditures | 1.5M | 2.3M | 1.0M | 72K | 5K | 4.8K | |
| Net Income | (28.9M) | (6.0M) | (16.1M) | (15.6M) | (14.0M) | (14.7M) | |
| End Period Cash Flow | 8.4M | 16.0M | 28.7M | 20.6M | 6.5M | 6.2M | |
| Investments | (6.9M) | 20.1M | 16.6M | 1.4M | (4.1M) | (3.9M) | |
| Change To Netincome | (7.7M) | 10.8M | (14.9M) | (9.3M) | (8.3M) | (7.9M) | |
| Change Receivables | (703K) | 1.1M | (437K) | (1.1M) | (1.0M) | (956.7K) |
Arcadia Biosciences Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Arcadia Biosciences or Food Products sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Arcadia Biosciences' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Arcadia stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.18 | |
β | Beta against Dow Jones | 2.59 | |
σ | Overall volatility | 6.57 | |
Ir | Information ratio | 0.0007 |
Arcadia Biosciences Volatility Alert
Arcadia Biosciences is displaying above-average volatility over the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Arcadia Biosciences' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Arcadia Biosciences' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Arcadia Biosciences Fundamentals Vs Peers
Comparing Arcadia Biosciences' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Arcadia Biosciences' direct or indirect competition across all of the common fundamentals between Arcadia Biosciences and the related equities. This way, we can detect undervalued stocks with similar characteristics as Arcadia Biosciences or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Arcadia Biosciences' fundamental indicators could also be used in its relative valuation, which is a method of valuing Arcadia Biosciences by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Arcadia Biosciences to competition |
| Fundamentals | Arcadia Biosciences | Peer Average |
| Return On Equity | -0.53 | -0.31 |
| Return On Asset | -0.39 | -0.14 |
| Profit Margin | (1.12) % | (1.27) % |
| Operating Margin | (1.15) % | (5.51) % |
| Current Valuation | (2.42 M) | 16.62 B |
| Shares Outstanding | 1.36 M | 571.82 M |
| Shares Owned By Insiders | 2.70 % | 10.09 % |
| Shares Owned By Institutions | 4.59 % | 39.21 % |
| Number Of Shares Shorted | 19.62 K | 4.71 M |
| Price To Earning | 4.84 X | 28.72 X |
| Price To Book | 0.37 X | 9.51 X |
| Price To Sales | 0.73 X | 11.42 X |
| Revenue | 5.33 M | 9.43 B |
| Gross Profit | (2.22 M) | 27.38 B |
| EBITDA | (13.58 M) | 3.9 B |
| Net Income | (13.99 M) | 570.98 M |
| Cash And Equivalents | 21.23 M | 2.7 B |
| Cash Per Share | 0.96 X | 5.01 X |
| Total Debt | 1.01 M | 5.32 B |
| Debt To Equity | 0.09 % | 48.70 % |
| Current Ratio | 6.34 X | 2.16 X |
| Book Value Per Share | 7.54 X | 1.93 K |
| Cash Flow From Operations | (15.29 M) | 971.22 M |
| Short Ratio | 0.71 X | 4.00 X |
| Earnings Per Share | (6.77) X | 3.12 X |
| Price To Earnings To Growth | (0.08) X | 4.89 X |
| Target Price | 9.0 | |
| Number Of Employees | 21 | 18.84 K |
| Beta | 1.27 | -0.15 |
| Market Capitalization | 3.81 M | 19.03 B |
| Total Asset | 19.7 M | 29.47 B |
| Retained Earnings | (271.84 M) | 9.33 B |
| Working Capital | 11.38 M | 1.48 B |
Note: Acquisition by Thomas Schaefer of 20000 shares of Arcadia Biosciences at 2.71 subject to Rule 16b-3 [view details]
Arcadia Biosciences Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Arcadia . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Arcadia Biosciences Buy or Sell Advice
When is the right time to buy or sell Arcadia Biosciences? Buying financial instruments such as Arcadia Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Arcadia Biosciences in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Railroads Thematic Idea Now
Railroads
Companies involved in manufacturing and maintenance of freight railroads and passenger trains as well as providing railroad services to public. The Railroads theme has 38 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Railroads Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Arcadia Biosciences Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For information on how to trade Arcadia Stock refer to our How to Trade Arcadia Stock guide.You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Is Agricultural Products & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Arcadia Biosciences. If investors know Arcadia will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Arcadia Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.285 | Earnings Share (6.77) | Revenue Per Share 3.802 | Quarterly Revenue Growth (0.04) | Return On Assets (0.39) |
The market value of Arcadia Biosciences is measured differently than its book value, which is the value of Arcadia that is recorded on the company's balance sheet. Investors also form their own opinion of Arcadia Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Arcadia Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Arcadia Biosciences' market value can be influenced by many factors that don't directly affect Arcadia Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Arcadia Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Arcadia Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Arcadia Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.